Singapore markets closed

Treace Medical Concepts, Inc. (TMCI)

NasdaqGS - NasdaqGS Real-time price. Currency in USD
Add to watchlist
13.05+0.69 (+5.58%)
At close: 04:00PM EDT
13.05 +0.00 (+0.01%)
After hours: 04:04PM EDT
Currency in USD

Valuation measures4

Market cap (intra-day) 763.29M
Enterprise value 710.40M
Trailing P/E N/A
Forward P/E N/A
PEG Ratio (5 yr expected) N/A
Price/sales (ttm)4.02
Price/book (mrq)5.53
Enterprise value/revenue 3.80
Enterprise value/EBITDA -18.21

Trading information

Stock price history

Beta (5Y monthly) 0.28
52-week change 3-51.94%
S&P500 52-week change 329.57%
52-week high 327.97
52-week low 35.27
50-day moving average 313.49
200-day moving average 314.71

Share statistics

Avg vol (3-month) 3526.95k
Avg vol (10-day) 3438.1k
Shares outstanding 561.76M
Implied shares outstanding 661.76M
Float 844.22M
% held by insiders 129.02%
% held by institutions 167.76%
Shares short (15 Mar 2024) 42.93M
Short ratio (15 Mar 2024) 46.49
Short % of float (15 Mar 2024) 48.53%
Short % of shares outstanding (15 Mar 2024) 44.75%
Shares short (prior month 15 Feb 2024) 42.86M

Dividends & splits

Forward annual dividend rate 4N/A
Forward annual dividend yield 4N/A
Trailing annual dividend rate 30.00
Trailing annual dividend yield 30.00%
5-year average dividend yield 4N/A
Payout ratio 40.00%
Dividend date 3N/A
Ex-dividend date 4N/A
Last split factor 2N/A
Last split date 3N/A

Financial highlights

Fiscal year

Fiscal year ends 31 Dec 2023
Most-recent quarter (mrq)31 Dec 2023

Profitability

Profit margin -26.47%
Operating margin (ttm)-10.78%

Management effectiveness

Return on assets (ttm)-15.59%
Return on equity (ttm)-49.91%

Income statement

Revenue (ttm)187.12M
Revenue per share (ttm)3.08
Quarterly revenue growth (yoy)25.00%
Gross profit (ttm)N/A
EBITDA -46.39M
Net income avi to common (ttm)-49.53M
Diluted EPS (ttm)-0.81
Quarterly earnings growth (yoy)N/A

Balance sheet

Total cash (mrq)123.2M
Total cash per share (mrq)2
Total debt (mrq)70.3M
Total debt/equity (mrq)50.97%
Current ratio (mrq)4.41
Book value per share (mrq)2.23

Cash flow statement

Operating cash flow (ttm)-34.58M
Levered free cash flow (ttm)-33.02M